WO2024254461A3 - Procédés et compositions pour le développement et la distribution de vaccins - Google Patents
Procédés et compositions pour le développement et la distribution de vaccins Download PDFInfo
- Publication number
- WO2024254461A3 WO2024254461A3 PCT/US2024/033024 US2024033024W WO2024254461A3 WO 2024254461 A3 WO2024254461 A3 WO 2024254461A3 US 2024033024 W US2024033024 W US 2024033024W WO 2024254461 A3 WO2024254461 A3 WO 2024254461A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- methods
- delivery
- vaccine development
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Ce document décrit des procédés et des compositions qui peuvent être utilisés pour développer et administrer rapidement de nouveaux vaccins.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363471614P | 2023-06-07 | 2023-06-07 | |
| US63/471,614 | 2023-06-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2024254461A2 WO2024254461A2 (fr) | 2024-12-12 |
| WO2024254461A3 true WO2024254461A3 (fr) | 2025-01-09 |
Family
ID=93794636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2024/033024 Ceased WO2024254461A2 (fr) | 2023-06-07 | 2024-06-07 | Procédés et compositions pour le développement et la distribution de vaccins |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2024254461A2 (fr) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210196806A1 (en) * | 2018-05-23 | 2021-07-01 | Gritstone Oncology, Inc. | Shared antigens |
| US20210252133A1 (en) * | 2018-08-17 | 2021-08-19 | Glaxosmithkline Biologicals Sa | Immunogenic compositions and uses thereof |
| US20220106257A1 (en) * | 2020-07-16 | 2022-04-07 | Acuitas Therapeutics, Inc. | Cationic lipids for use in lipid nanoparticles |
| WO2022173730A1 (fr) * | 2021-02-09 | 2022-08-18 | Virginia Commonwealth University | Thérapies et vaccins à base de mini-arn circulaire et leurs procédés d'utilisation |
-
2024
- 2024-06-07 WO PCT/US2024/033024 patent/WO2024254461A2/fr not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210196806A1 (en) * | 2018-05-23 | 2021-07-01 | Gritstone Oncology, Inc. | Shared antigens |
| US20210252133A1 (en) * | 2018-08-17 | 2021-08-19 | Glaxosmithkline Biologicals Sa | Immunogenic compositions and uses thereof |
| US20220106257A1 (en) * | 2020-07-16 | 2022-04-07 | Acuitas Therapeutics, Inc. | Cationic lipids for use in lipid nanoparticles |
| WO2022173730A1 (fr) * | 2021-02-09 | 2022-08-18 | Virginia Commonwealth University | Thérapies et vaccins à base de mini-arn circulaire et leurs procédés d'utilisation |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024254461A2 (fr) | 2024-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1013780B8 (pt) | Composição imunogênica útil para imunização contra staphylococcus aureus, seu método de preparação e composição farmacêutica | |
| EP4110383A4 (fr) | Compositions et méthodes de vaccination mucosale contre le sars-cov-2 | |
| EP3725328A3 (fr) | Nouvelles compositions d'adjuvants | |
| EP4494650A3 (fr) | Compositions vaccinales ayant une stabilite et une immunogenicite ameliorees | |
| WO2013006842A3 (fr) | Compositions immunogènes et leurs utilisations | |
| WO2015120110A3 (fr) | Nouvelles formulations pharmaceutiques | |
| TW200806316A (en) | Yeast-based vaccine for inducing an immune response | |
| EP4241850A3 (fr) | Inhibiteurs de mdm2 et combinaisons de ceux-ci | |
| SA517390550B1 (ar) | وحدة جرعة قابلة للتفتت في الفم تتضمن مكون أستيترول | |
| EP4461369A3 (fr) | Compositions en aérosol comprenant des mitochondries et leurs méthodes d'utilisation | |
| EP4335851A3 (fr) | Formulations pharmaceutiques et leurs procédés d'utilisation | |
| PH12019500330A1 (en) | Porcine epidemic diarrhea preventative or therapeutic method, vaccine, and vaccine kit | |
| EP4248992A3 (fr) | Vaccin contre la fièvre aphteuse | |
| MY189495A (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| AU2019366996A8 (en) | Polymer-lipids and compositions | |
| EP3000464A3 (fr) | Composition comprenant du farnésol et son utilisation | |
| PH12018501368A1 (en) | M hyo multivalent vaccine and uses thereof | |
| WO2020012428A8 (fr) | Nouveaux vaccins contre les réovirus aviaires | |
| ZA202104747B (en) | Novel trypanosomal vaccine | |
| MX2021011913A (es) | Composiciones de virus inactivado y formulaciones de vacunas contra el zika. | |
| WO2024254461A3 (fr) | Procédés et compositions pour le développement et la distribution de vaccins | |
| AU2018347511A8 (en) | Periodontitis vaccine and related compositions and method of use | |
| ZA202104746B (en) | Novel trypanosomal vaccine | |
| EP4165075A4 (fr) | Compositions de vaccin contre le vih, procédés et utilisations associées | |
| WO2005056769A3 (fr) | Vaccins a souche de bacterie vivante administres par voie orale contre la peste |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |